 Connection
Wendy Armstrong to Cost-Benefit Analysis
This is a "connection" page, showing publications Wendy Armstrong has written about Cost-Benefit Analysis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.210 |
|
|
|
-
Del Rio C, Armstrong WS. How Much Are We Willing to Pay for Preexposure Prophylaxis in the United States? Ann Intern Med. 2020 05 05; 172(9):623-624.
Score: 0.136
-
Quan AML, Mah C, Krebs E, Zang X, Chen S, Althoff K, Armstrong W, Behrends CN, Dombrowski JC, Enns E, Feaster DJ, Gebo KA, Goedel WC, Golden M, Marshall BDL, Mehta SH, Pandya A, Schackman BR, Strathdee SA, Sullivan P, Tookes H, Nosyk B. Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities. Lancet HIV. 2021 09; 8(9):e581-e590.
Score: 0.037
-
Zang X, Krebs E, Chen S, Piske M, Armstrong WS, Behrends CN, Del Rio C, Feaster DJ, Marshall BDL, Mehta SH, Mermin J, Metsch LR, Schackman BR, Strathdee SA, Nosyk B. The Potential Epidemiological Impact of Coronavirus Disease 2019 (COVID-19) on the Human Immunodeficiency Virus (HIV) Epidemic and the Cost-effectiveness of Linked, Opt-out HIV Testing: A Modeling Study in 6 US Cities. Clin Infect Dis. 2021 06 01; 72(11):e828-e834.
Score: 0.037
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|